World's 1st transplant surgery using iPS cells conducted

KOBE, Japan - Masayo Takahashi, researcher of the Riken Center for Developmental Biology, holds a press conference in Kobe, western Japan, on Sept. 12, 2014, after a Japanese research team led by Takahashi transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s. It marked the first time iPS-derived cells have been introduced into a human body by surgery.

Sample
PDF Preview

Product Code
ILEA001206690

Registered date
2014/9/12 00:00:00

Credit
Kyodo / Kyodo News Images

Media source
2014 Kyodo News

Media size
1880 × 2515 pixel

Resolution
240 dpi

Deployment size
464.76(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Japan startup lander may reach Moon on Apr. 26

Takeshi Hakamada, founder and CEO of Japanese space startup Ispace Inc., holds a press conference in Tokyo on April 12, 2023. He announced the company's self-developed Moon lander may touch down on the celestial body as early as April 26, a move that would make it the first private company in the world to reach the Moon.

Japan's new supercomputer ranked fastest in world

Hiroshi Matsumoto, president of Japan's state-backed Riken research institute, speaks at a press conference in Kobe on June 23, 2020, after new supercomputer Fugaku, jointly developed with the institute's Center for Computational Science and Fujitsu Ltd., was recognized as having the fastest computing speed in the world. (Kyodo) ==Kyodo

Japan's new supercomputer ranked fastest in world

Hiroshi Matsumoto (C), president of Japan's state-backed Riken research institute, attends a press conference in Kobe on June 23, 2020, after new supercomputer Fugaku, jointly developed with the institute's Center for Computational Science and Fujitsu Ltd., was recognized as having the fastest computing speed in the world. (Kyodo) ==Kyodo

Japan's new supercomputer ranked fastest in world

Renowned researcher leaves Riken institute

Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute who led a team that succeeded for the first time in the world in transplanting into a woman retinal cells grown from her own iPS cells in 2014. Riken announced on July 31, 2019, that Takahashi will leave the institute the same day. (Kyodo) ==Kyodo

Retina transplants via donor iPS cells

Masayo Takahashi, a researcher at the Japanese government-backed Riken institute, speaks at an academic conference in Tokyo on April 18, 2019. Five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors, she said. (Kyodo) ==Kyodo

Retina transplants via donor iPS cells

Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute. She said in Tokyo on April 18, 2019 that five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors. (Kyodo) ==Kyodo

Nobel laureate researcher Shinya Yamanaka

KYOTO, Japan, Dec. 19 Kyodo - Nobel laureate researcher Shinya Yamanaka, who heads Kyoto University's Center for iPS Cell Research and Application, speaks at a press conference in Kyoto on Dec. 18, 2018.

Purported "STAP cells" likely came from embryonic stem cells

TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21.

Purported "STAP cells" likely came from embryonic stem cells

TOKYO, Japan - Isao Katsura, director general of the National Institute of Genetics and leader of a panel under the Riken research institute, attends a press conference in Tokyo on Dec. 26, 2014, to announce that the "STAP cells" that scientist Haruko Obokata, who left Riken on Dec. 21, claimed to have created were likely cells generated from embryonic stem cells.